Financial News
All
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
Macro
All Sentiment
Bullish
Neutral
Bearish
1,958 articles
📰
Sutro Biopharma Reports Full Year 2025 Financial Results and Business Highlights
– Dosed three cohorts in Phase 1 trial of STRO-004, potential best-in-class Tissue Factor (TF) ADC; on track to report initial clinical data in...
📰
Surrozen Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Expect to submit an Investigational New Drug application for SZN-8141 to FDA in the second half of 2026
Scheduled to present retinal vascular...
📰
Why ImmunityBio Stock Is Up More Than 11% Today
The young biopharma outfit's growth potential continues to expand.
Crude Oil Falls Sharply; Dell Shares Spike Higher
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 350 points on Monday.
The Dow traded up 1.81% to...
Crude Oil Falls Sharply; Dell Shares Spike Higher
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 350 points on Monday.
The Dow traded up 1.81% to...
Crude Oil Falls Sharply; Dell Shares Spike Higher
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 350 points on Monday.
The Dow traded up 1.81% to...
Crude Oil Falls Sharply; Dell Shares Spike Higher
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 350 points on Monday.
The Dow traded up 1.81% to...
📰
Why Viking Therapeutics Stock Could Take Off Later This Year
Some key clinical trial data is expected soon.
📰
Why AbbVie Stock Looks Like a Dirt Cheap Buy Right Now
AbbVie has strong financials, a great dividend, and its stock trades at a modest valuation.
Utah's Forgotten Uranium Belt Is Getting a Second Look. Here's Why the Timing Matters.
Issued on behalf of EagleOne Metals Corporation VANCOUVER, BC, March 23, 2026 /PRNewswire/ -- Equity-Insider.com — Thirty-five miles south of...
Eupraxia Pharmaceuticals Boasts $900 Million Peak Sales Potential: Analyst
William Blair on Monday initiated coverage on Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX), a clinical-stage biotechnology company focused on the...
Eupraxia Pharmaceuticals Boasts $900 Million Peak Sales Potential: Analyst
William Blair on Monday initiated coverage on Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX), a clinical-stage biotechnology company focused on the...
Eupraxia Pharmaceuticals Boasts $900 Million Peak Sales Potential: Analyst
William Blair on Monday initiated coverage on Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX), a clinical-stage biotechnology company focused on the...
GE Vernova Set For Strong 2026 Gas Power Orders: Analyst
GE Vernova Inc. (NYSE:GEV) shares are trading higher on Monday. The company has been in the news lately due to its investment in facility expansion...
Why Is Oracle Trading Higher Monday?
Oracle Corp (NYSE:ORCL) shares moved higher Monday as improving geopolitical sentiment lifted tech stocks and broader market momentum.
The stock...
What's Going On With Nvidia Stock Monday?
Nvidia Corp. (NASDAQ:NVDA) shares climbed Monday, tracking a broader market rebound after President Donald Trump announced a five-day pause on...
PANTHERx® Rare Selected by UCB as the Exclusive Specialty Pharmacy for the Distribution of KYGEVVI™
PITTSBURGH, March 23, 2026 /PRNewswire/ -- PANTHERx® Rare, the trusted leader and innovator in patient access and support services for personalized...
Small Caps Rally, Oil Sinks 8% After Trump's 5-Day Iran Strike Pause: What's Moving Markets Monday?
A sharp contradiction between President Donald Trump and Iran did little to unsettle investors as U.S. equities staged a broad, relief-driven rebound...
📰
Biohaven Stock Down 70% but One Fund's New $6 Million Bet Signals Turnaround Potential
This clinical-stage biotech focuses on developing therapies for neurological and immunoscience disorders.
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers
bioAffinity Technologies (NASDAQ:BIAF) shares rose 89.4% to $5.17 during Monday's regular session. The market value of their...
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers
bioAffinity Technologies (NASDAQ:BIAF) shares rose 89.4% to $5.17 during Monday's regular session. The market value of their...
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers
bioAffinity Technologies (NASDAQ:BIAF) shares rose 89.4% to $5.17 during Monday's regular session. The market value of their...
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers
bioAffinity Technologies (NASDAQ:BIAF) shares rose 89.4% to $5.17 during Monday's regular session. The market value of their...
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers
bioAffinity Technologies (NASDAQ:BIAF) shares rose 89.4% to $5.17 during Monday's regular session. The market value of their...
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers
bioAffinity Technologies (NASDAQ:BIAF) shares rose 89.4% to $5.17 during Monday's regular session. The market value of their...
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers
bioAffinity Technologies (NASDAQ:BIAF) shares rose 89.4% to $5.17 during Monday's regular session. The market value of their...
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers
bioAffinity Technologies (NASDAQ:BIAF) shares rose 89.4% to $5.17 during Monday's regular session. The market value of their...
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers
bioAffinity Technologies (NASDAQ:BIAF) shares rose 89.4% to $5.17 during Monday's regular session. The market value of their...
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers
bioAffinity Technologies (NASDAQ:BIAF) shares rose 89.4% to $5.17 during Monday's regular session. The market value of their...
Apple Foldable iPhone Leak: BofA Predicts 20 Million Sales As 2026 Launch Looms
BofA Securities sees Apple Inc's (NASDAQ:AAPL) upcoming product shifts and launch strategy as key drivers for future growth, despite a slight...
Insmed Lung Infection Therapy Data Impresses, Analyst Sees Approval Path
Insmed Incorporated (NASDAQ:INSM) shares are up during Monday’s session following the announcement of positive topline results from the Phase...
📰
A $175 Million Move Into Sotera Health Signals Potential Opportunity Amid 21% Stock Drop
Sotera Health delivers sterilization and lab testing services to global medical and pharmaceutical supply chains.
Embecta to Acquire Owen Mumford to Expand Drug-Delivery Portfolio
EMBC to acquire Owen Mumford for up to $199.4M, aiming to expand beyond diabetes into high-value drug delivery and boost long-term growth.
Embecta to Acquire Owen Mumford to Expand Drug-Delivery Portfolio
EMBC to acquire Owen Mumford for up to $199.4M, aiming to expand beyond diabetes into high-value drug delivery and boost long-term growth.
Embecta to Acquire Owen Mumford to Expand Drug-Delivery Portfolio
EMBC to acquire Owen Mumford for up to $199.4M, aiming to expand beyond diabetes into high-value drug delivery and boost long-term growth.
Embecta to Acquire Owen Mumford to Expand Drug-Delivery Portfolio
EMBC to acquire Owen Mumford for up to $199.4M, aiming to expand beyond diabetes into high-value drug delivery and boost long-term growth.
Tempus AI's Diagnostics and Data Arms Drive Long-Term Growth Story
Tempus AI's dual-engine model drives $1.27B revenues, with Diagnostics dominating and Data monetization accelerating growth and pricing leverage.
Tempus AI's Diagnostics and Data Arms Drive Long-Term Growth Story
Tempus AI's dual-engine model drives $1.27B revenues, with Diagnostics dominating and Data monetization accelerating growth and pricing leverage.
Tempus AI's Diagnostics and Data Arms Drive Long-Term Growth Story
Tempus AI's dual-engine model drives $1.27B revenues, with Diagnostics dominating and Data monetization accelerating growth and pricing leverage.
📰
Here's How Much You Would Have Made Owning McKesson Stock In The Last 20 Years
McKesson (NYSE:MCK) has outperformed the market over the past 20 years by 6.72% on an annualized basis producing an average annual return of 15.2%....
📰
BioStem Appoints Jodi Ungrodt to Board of Directors as Audit Committee Chair
SEC-Qualified Financial Expert and Life Sciences Veteran Brings 29 Years of Accounting Leadership to the Board SEC-Qualified Financial Expert and...